Health Research Board

1.   Definitions

In these Regulations,

1.1 “Acceptance Documentation” means the documentation to be completed/executed by the Host Institution and where relevant, the Principal Investigator as specified in the Grant Letter.

1.2  “Annual Report” means the report to be submitted by the Host Institution to the HRB in accordance with clause 6.1. 

1.3  “Application” means the application submitted by or on behalf of the Host Institution, all documents attached thereto and all other documentation furnished to the HRB prior to the issuing of the Grant Letter.

1.4 “Asset” means any asset, including buildings or equipment, acquired, generated or established directly or indirectly in connection with the Grant Funded Activities or any part of them.

1.5 “Budget” means the budget (if any) identified in the Grant Letter and any binding variation.

1.6 “Business Day” means a day which is not a Saturday or a Sunday or public holiday in Ireland on which banks in Dublin are generally open for business. 

1.7 “Commencement Date” means the date referred to in Clause 17.1.1 or 17.1.2 as the case may be.

1.8  “End-of-Grant Report” means the report to be furnished by the Host Institution to the HRB in accordance with clause 6.1.

1.9 “Financial Records” means such ledgers, bank statements, accounts, invoices, vouching documentation, authorities, directions and also instructions to auditors, accountants, banks and other servants or agents of the Host Institution and any other papers in both paper and electronic form which may be reasonably necessary to enable the HRB exercise its rights of audit and to satisfy the HRB that the Host Institution has complied with the Grant Conditions. 

1.10 “General Terms and Conditions” means the terms, conditions, warranties and obligations set out in this document and the schedules hereto together with any binding variation. 

1.11 “Grant” means the grant awarded by the Grant Letter. 

1.12 “Grant Conditions” means collectively the Application, the Acceptance Documentation the Grant Letter and the appendices thereto (including these General Terms and Conditions). 

1.13 “Grant Funded Activities” means the activities in respect of which the Grant is awarded as set out in the Grant Letter.

1.14 “Grant Letter” means the letter issued by the HRB to the Host Institution awarding a Grant and all documents ancillary thereto. 

1.15 “Host Institution” means the body or person to whom a Grant Letter is addressed. 

1.16  “HRB” means the Health Research Board established under S.I. No. 279 of 1986 as amended. 

1.17 “Intellectual Property” means all intellectual property produced in connection with the Grant Funded Activities including copyrights, patents, design rights, trade secrets, confidential information, trademarks, trade names, domain names, service marks, utility models, moral rights, topography rights, rights and databases and know-how in all cases whether or not registered or registrable and including registrations and applications for registration of any of these rights and all rights and forms of protection of a similar nature or having equivalent or similar effect to any of these anywhere in the world. 

1.18 “Intellectual Property Guidelines” means the Funding Agencies Requirements and Guidelines for Managing Research Generated Intellectual Property 2006 which is available on the HRB’s website as same may be amended from time to time.

1.19 “Interim Report” means the report to the submitted by the Host Institution to the HRB in accordance with Clause 6.2.

1.20 “Misconduct” means fabrication (including without limitation the making up of data or results and recording or reporting them), falsification (including but not limited to manipulating research materials, equipment or processes or changing or omitting data or results such that the research is not accurately represented in the research record), plagiarism (the appropriation of another person’s ideas, processes, results or words without giving appropriate credit) or other serious deviation from accepted practices.

1.21“Principal Investigator” means the individual employed or otherwise engaged by the Host Institution nominated as such by the Host Institution and named in the Grant Letter and in the case of a Fellowship Grant means the individual named in the Grant Letter. 

1.22 “PubMed Central” means a free digital archive of biomedical and life science journal literature operated by the National Centre for Biotechnology Information, a division of the US National Library of Medicine. 

1.23 “Subject Invention” means any invention or process conceived or first actively reduced to practice in the performance of the Grant Funded Activities.

1.24 “Team” means the Principal Investigator, staff, students, visiting researchers and others employed, involved or otherwise engaged by the Host Institution for the purposes of the Grant Funded Activities.

1.25 “Term” means the period specified in the Grant Letter commencing on the Commencement Date. 

1.26 “UK PubMed Central” means a UK counterpart of PubMed Central developed by the Wellcome Trust and other funders (www.ukpmc.ac.uk).